Worldquant Millennium Advisors LLC Bristol Myers Squibb CO Transaction History

Worldquant Millennium Advisors LLC

$22.3 Billion
Q3 2025

A detailed history of Worldquant Millennium Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 3,161,440 shares of BMY stock, worth $148 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

3,161,440

Previous 19,508 16105.86%

Holding current value

$148 Million

Previous $903,000 15689.59%

% of portfolio

0.64%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$43.31 - $48.98 $136 Million - $154 Million	3,141,932 Added 16105.86%	3,161,440 $143 Million
Q2 2025 Aug 14, 2025	SELL	$44.12 - $59.6 $24 Million - $32.4 Million	-544,370 Reduced 96.54%	19,508 $903,000
Q1 2025 May 15, 2025	BUY	$53.9 - $63.11 $30.4 Million - $35.6 Million	563,878 New	563,878 $34.4 Million
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $10 Million - $13.1 Million	253,040 Added 84.17%	553,656 $28.7 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $12.1 Million - $15.9 Million	300,616 New	300,616 $12.5 Million

Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $9.5 Million - $11.3 Million	196,052 Added 34.76%	760,013 $39 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $2.11 Million - $2.36 Million	36,530 Added 6.93%	563,961 $32.7 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $11 Million - $12.2 Million	-172,534 Reduced 24.65%	527,431 $33.7 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $41.1 Million - $46.6 Million	624,930 Added 832.85%	699,965 $48.5 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $5.14 Million - $6.08 Million	75,035 New	75,035 $5.4 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $14.4 Million - $15.9 Million	-198,439 Reduced 84.34%	36,837 $2.84 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $20.8 Million - $24.9 Million	-338,325 Reduced 58.98%	235,276 $17.2 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $11.2 Million - $13.1 Million	208,908 Added 57.28%	573,601 $35.8 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $6.67 Million - $7.82 Million	-112,768 Reduced 23.62%	364,693 $21.6 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $10.4 Million - $11.3 Million	-167,596 Reduced 25.98%	477,461 $31.9 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $4.15 Million - $4.66 Million	69,874 Added 12.15%	645,057 $40.7 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $11.3 Million - $12.6 Million	197,498 Added 52.29%	575,183 $34.7 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $7.75 Million - $9.06 Million	141,378 Added 59.83%	377,685 $22.2 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $651,177 - $946,312	-14,034 Reduced 5.61%	236,307 $13.2 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $24.2 Million - $31.6 Million	-491,937 Reduced 66.27%	250,341 $16.1 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $73.2 Million - $86.7 Million	-1,710,706 Reduced 69.74%	742,278 $37.6 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $37.8 Million - $41.8 Million	846,212 Added 52.67%	2,452,984 $111 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $36.9 Million - $44 Million	818,362 Added 103.8%	1,606,772 $76.7 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $10.9 Million - $14.1 Million	223,138 Added 39.47%	788,410 $41 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $6.94 Million - $7.82 Million	-125,697 Reduced 18.19%	565,272 $35.1 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $34.9 Million - $43.5 Million	690,969 New	690,969 $38.2 Million

Others Institutions Holding BMY

# of Institutions

2,680

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.

Account

Worldquant Millennium Advisors LLC Bristol Myers Squibb CO Transaction History